BioCentury
ARTICLE | Management Tracks

Fedock to succeed Bruehlman as CFO of IQVIA 

Plus: NMD names Ana de Vera CMO and updates from Kala Bio and Adagene

September 5, 2025 11:49 PM UTC

IQVIA Holdings Inc. (NYSE:IQV) has promoted Michael Fedock, SVP of financial planning & analysis, to EVP and CFO effective February. He will succeed Ron Bruehlman, who joined the company in 2011 and is retiring.

Danish neuromuscular diseases company NMD Pharma A/S hired Ana de Vera as CMO. She was head of development and deputy CMO at Santhera Pharmaceuticals Holding AG (SIX:SANN)...